- Home
- ISD vs AMRN Comparison
ISD vs AMRN Comparison
Compare ISD & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ISD | AMRN |
|---|---|---|
| Founded | 2012 | 1989 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 426.8M | 342.8M |
| IPO Year | N/A | 1998 |
Fundamental Metrics
Financial Performance| Metric | ISD | AMRN |
|---|---|---|
| Price | $12.83 | $13.94 |
| Analyst Decision | | Strong Sell |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | ★ 109.9K | 82.2K |
| Earning Date | 01-01-0001 | 04-29-2026 |
| Dividend Yield | ★ 9.69% | N/A |
| EPS Growth | N/A | ★ 55.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $181,104,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.26 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 39.22 |
| 52 Week Low | $12.53 | $12.96 |
| 52 Week High | $14.79 | $20.90 |
Technical Indicators
Market Signals| Indicator | ISD | AMRN |
|---|---|---|
| Relative Strength Index (RSI) | 49.03 | 37.46 |
| Support Level | $12.75 | $13.58 |
| Resistance Level | $13.15 | $14.49 |
| Average True Range (ATR) | 0.15 | 0.59 |
| MACD | -0.00 | -0.22 |
| Stochastic Oscillator | 42.22 | 16.11 |
Price Performance
Historical ComparisonAbout ISD PGIM High Yield Bond Fund Inc.
PGIM High Yield Fund Inc is a diversified, closed-end management investment company, active in the financial services domain. The fund's primary investment objective is to provide a high level of current income, with its secondary objective being capital appreciation. It invests at least eighty percent of its investable assets in a diversified portfolio of high-yield fixed-income instruments that are rated below investment grade with varying maturities and other investments.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a pharmaceutical company. The company is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa. The company focuses on treatments to stop cardiovascular disease causing death, by providing patients, doctors and investors with reliable cardiovascular treatment options. Geographically, the company derives maximum revenue from United States.